These TREX1 mutations have been reported to associate with microcephaly, chilblains-like lesions, severe tetraparesis, cerebral calcifications, leukodystrophy, and raised cerebrospinal fluid IFNα, all typical clinical features of AGS (Olivieri et al., 2013). This evidence concerns the gene TREX1 and microcephaly.